Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie A Vendrell

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Diseases (Basel, Switzerland)|October 28, 2025
Real-World Technical Hurdles of ctDNA NGS Analysis: Lessons from Clinical ImplementationSimon Cabello-Aguilar, Julie A Vendrell, Jérôme Solassol
Current Issues in Molecular Biology|December 22, 2023
A Bioinformatics Toolkit for Next-Generation Sequencing in Clinical OncologySimon Cabello-Aguilar, Julie A Vendrell, Jérôme Solassol
Therapeutic Advances in Medical Oncology|January 8, 2021
Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatmentJulie A Vendrell, Xavier Quantin, Isabelle Serre, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2018
Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration DetectionJulie A Vendrell, Paul Vilquin, Marion Larrieux, et al.
Translational Lung Cancer Research|January 10, 2022
EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcomeJulie A Vendrell, Xavier Quantin, Audrey Aussel, et al.
Oncotarget|October 3, 2015
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker valuePascale A Cohen, Caterina F Donini, Nhan T Nguyen, et al.
International Journal of Molecular Sciences|February 15, 2022
Determination of the Optimal Bacterial DNA Extraction Method to Explore the Urinary MicrobiotaJulie A Vendrell, Steven Henry, Simon Cabello-Aguilar, et al.
BMC Cancer|May 5, 2026
Integrated DNA and RNA profiling refines prognostic stratification independent of therapeutic actionability in cholangiocarcinomaJulie A Vendrell, Inès Dalmon, Simon Cabello-Aguilar, et al.
International Journal of Molecular Sciences|February 2, 2017
Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient ManagementJulie A Vendrell, Frédéric Tran Mau-Them, Benoît Béganton, et al.
International Journal of Cancer|July 18, 2009
Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathwaysSandra E Ghayad, Julie A Vendrell, Sabrina Ben Larbi, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Diseases (Basel, Switzerland)|October 28, 2025
Real-World Technical Hurdles of ctDNA NGS Analysis: Lessons from Clinical ImplementationSimon Cabello-Aguilar, Julie A Vendrell, Jérôme Solassol
Current Issues in Molecular Biology|December 22, 2023
A Bioinformatics Toolkit for Next-Generation Sequencing in Clinical OncologySimon Cabello-Aguilar, Julie A Vendrell, Jérôme Solassol
Therapeutic Advances in Medical Oncology|January 8, 2021
Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatmentJulie A Vendrell, Xavier Quantin, Isabelle Serre, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2018
Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration DetectionJulie A Vendrell, Paul Vilquin, Marion Larrieux, et al.
Translational Lung Cancer Research|January 10, 2022
EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcomeJulie A Vendrell, Xavier Quantin, Audrey Aussel, et al.
Oncotarget|October 3, 2015
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker valuePascale A Cohen, Caterina F Donini, Nhan T Nguyen, et al.
International Journal of Molecular Sciences|February 15, 2022
Determination of the Optimal Bacterial DNA Extraction Method to Explore the Urinary MicrobiotaJulie A Vendrell, Steven Henry, Simon Cabello-Aguilar, et al.
BMC Cancer|May 5, 2026
Integrated DNA and RNA profiling refines prognostic stratification independent of therapeutic actionability in cholangiocarcinomaJulie A Vendrell, Inès Dalmon, Simon Cabello-Aguilar, et al.
International Journal of Molecular Sciences|February 2, 2017
Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient ManagementJulie A Vendrell, Frédéric Tran Mau-Them, Benoît Béganton, et al.
International Journal of Cancer|July 18, 2009
Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathwaysSandra E Ghayad, Julie A Vendrell, Sabrina Ben Larbi, et al.
Pageof 4